Asset Details
Do you wish to reserve the book?
Lung neuroendocrine neoplasms: recent progress and persistent challenges
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Lung neuroendocrine neoplasms: recent progress and persistent challenges
Do you wish to request the book?
Lung neuroendocrine neoplasms: recent progress and persistent challenges
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Lung neuroendocrine neoplasms: recent progress and persistent challenges
2022
Overview
This review summarizes key recent developments relevant to the pathologic diagnosis of lung neuroendocrine neoplasms, including carcinoids, small cell lung carcinoma (SCLC), and large cell neuroendocrine carcinoma (LCNEC). Covered are recent insights into the biological subtypes within each main tumor type, progress in pathological diagnosis and immunohistochemical markers, and persistent challenging areas. Highlighted topics include highly proliferative carcinoids and their distinction from small cell and large cell neuroendocrine carcinomas (NECs), the evolving role of Ki67, the update on the differential diagnosis of NEC to include thoracic SMARCA4-deficient undifferentiated tumors, the recent data on SCLC transcriptional subtypes with the emergence of POU2F3 as a novel marker for the diagnosis of SCLC with low/negative expression of standard neuroendocrine markers, and the update on the diagnosis of LCNEC, particularly in biopsies. There has been remarkable recent progress in the understanding of the genetic and expression-based profiles within each type of lung neuroendocrine neoplasm, and it is hoped that these insights will enable the development of novel diagnostic, prognostic, and predictive biomarkers to aid in the pathologic assessment of these tumors in the future.
Publisher
Elsevier Inc,Nature Publishing Group US,Elsevier Limited
Subject
/ Biomarkers, Tumor - genetics
/ Biopsy
/ Carcinoma, Neuroendocrine - diagnosis
/ Carcinoma, Neuroendocrine - genetics
/ Carcinoma, Neuroendocrine - pathology
/ Humans
/ Medicine
/ Small Cell Lung Carcinoma - diagnosis
/ Small Cell Lung Carcinoma - genetics
/ Small Cell Lung Carcinoma - pathology
/ Thorax
/ Tumors
